Pharmaceuticals US

US Aquaculture Health Products Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US Aquaculture Health Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Species, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $793.0 Mn Placeholder estimate
Estimate 2025 $837.4 Mn 39.9% of the global market
Projected 2034 $1.37 Bn 63.3% Adds $530.0 Mn over 9 forecast years
CAGR 2025–2034 5.6% Faster than 46% of 186 Pharmaceuticals markets here
Key players 5
  • US is 39.88% of the global market.
  • In North America, the largest is US (this report) at $837.4 Mn.
  • Fastest growing: Canada at 7.8% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$530.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Aquaculture Health Products Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $793.0 Mn — —
2025 (base) $837.4 Mn +$44.4 Mn —
2026 (forecast) $884.2 Mn +$46.9 Mn +5.6%
2027 (forecast) $933.8 Mn +$49.5 Mn +11.5%
2028 (forecast) $986.1 Mn +$52.3 Mn +17.8%
2029 (forecast) $1.04 Bn +$55.2 Mn +24.4%
2030 (forecast) $1.10 Bn +$58.3 Mn +31.3%
2031 (forecast) $1.16 Bn +$61.6 Mn +38.7%
2032 (forecast) $1.23 Bn +$65.0 Mn +46.4%
2033 (forecast) $1.29 Bn +$68.7 Mn +54.6%
2034 (forecast) $1.37 Bn +$72.5 Mn +63.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Aquaculture Health Products Market Analysis at a glance
Market size, 2025$837.4 Mn placeholder estimate
Forecast, 2034$1.37 Bn placeholder estimate
Growth (CAGR), 2025–20345.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledAquaculture Healthcare
SegmentsProduct and species (see all)
Key playersMerck & Co., Inc., Elanco, Benchmark Holdings, Zoetis, Inc, Vaxxinova (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Aquaculture Health Products Market Analysis Executive Summary

Aquaculture health products protect farmed fish and shrimp from disease with vaccines, feed additives and treatments.

Key segments of the aquaculture Health Products market include product (Vaccines, Antiparasitics and Probiotics) and species (Salmon, Shrimp and Tilapia).

Bar chart: US Aquaculture Health Products market size, 2024–2034, placeholder estimates. $793.0 Mn in 2024, $837.4 Mn in 2025 and $1.37 Bn in 2034, 5.6% CAGR.
US Aquaculture Health Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Aquaculture Health Products Market Dynamics

Market Growth Drivers

More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the aquaculture Health Products market.

Opportunity

Pet insurance, diagnostics and vaccines for emerging animal diseases give the aquaculture Health Products market room to grow.

Market Restraints

Cost-sensitive farmers, fewer vets in rural areas, rules on antibiotic use in animals and slow approvals hold back the aquaculture Health Products market.

Competitive Landscape for Aquaculture Health Products Market in the US

The aquaculture Health Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Aquaculture Health Products Market in the US

Aquaculture Health Products in the US: rules and payment

New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead.⁠[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[2]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for aquaculture Health Products. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in the US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Aquaculture Health Products right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Aquaculture Health Products in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Inside the US

Quick answers

Frequently asked questions

How big is the Aquaculture Health Products market in the US?
Placeholder estimate: about $837.4 Mn in 2025, rising to about $1.37 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Aquaculture Health Products market in the US growing?
Placeholder estimate: about 5.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Aquaculture Health Products market report cover?
The report splits the market by product (Vaccines, Antiparasitics, Probiotics, Water Treatment) and species (Salmon, Shrimp, Tilapia, Others).
Who are the key players in the Aquaculture Health Products market?
Key players include Merck & Co., Inc., Elanco, Benchmark Holdings, Zoetis, Inc and Vaxxinova.
What is driving the Aquaculture Health Products market?
More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the aquaculture Health Products market.
Who regulates Aquaculture Health Products in the US?
New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead. Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How much research is published on Aquaculture Health Products?
PubMed lists 83 papers on Aquaculture Health Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in US

See all

Related on animal health and vaccines

See the topic